The global healthcare sector is witnessing unprecedented innovation in rare disease management, with IgG4-related diseases representing a crucial breakthrough area in autoimmune medicine. These multisystem inflammatory disorders, once considered medical enigmas, are now driving substantial pharmaceutical investment and therapeutic development across multiple organ...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek